Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Search Product Recalls

Try:····

Filters

Time Period

All Time Last 30 Days Last 90 Days Last Year

State

Showing 81–100 of 548 results

Sort:

Newest first Oldest first

Tirzepatide Niacinamide Injection (Aequita) – Processing Controls (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Tirzepatide + Niacinamide Injection (Aequita Pharmacy) – Processing Controls Issue (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Semaglutide Cyanocobalamin Injection (Aequita) – Processing Controls (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Semaglutide Cyanocobalamin Injection (Aequita) – Processing Controls (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Tirzepatide + Niacinamide 16.6 mg Injection (Aequita Pharmacy) – Processing Controls Issue (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Semaglutide Cyanocobalamin Injection (Aequita) – Processing Controls (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Tirzepatide + Niacinamide 13.2 mg Injection (Aequita Pharmacy) – Processing Controls Issue (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Semaglutide Cyanocobalamin Injection (Aequita) – Processing Controls (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Semaglutide Cyanocobalamin Injection (Aequita) – Processing Controls (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Tirzepatide + Niacinamide 11.24 mg Injection (Aequita Pharmacy) – Processing Controls Issue (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Semaglutide + Cyanocobalamin Injection (Aequita Pharmacy) – Processing Controls Issue (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Tirzepatide Niacinamide Injection (Aequita) – Processing Controls (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Tirzepatide + Niacinamide 8.8 mg Injection (Aequita Pharmacy) – Processing Controls Issue (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

KleenFoam Soap (DermaRite Industries) – Microbial Contamination (2025)

Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.

Class IHigh

FDAJul 17, 2025Nationwide• DermaRite Industries, LLC

Sushi Wasabi (Ming Hong) – Undeclared Yellow 5 (2025)

Individual consumer size Wasabi mini pack label does not declare allergen ingredient Yellow 5.

Class IIModerate

FDAJul 16, 2025CA, CO, FL +17 more• MING HONG INTERNATIONAL INC.

Shave Power Stick Deodorant (A.P. Deauville) – Quality Control Issue (2025)

CGMP Deviations

Class IIModerate

FDAJul 10, 2025Nationwide• A.P. Deauville, LLC

Power Stick Roll-On Antiperspirant (A.P. Deauville) – Quality Control Issue (2025)

CGMP Deviations

Class IIModerate

FDAJul 10, 2025Nationwide• A.P. Deauville, LLC

Beauty Power Stick Deodorant (A.P. Deauville) – Quality Control Issue (2025)

CGMP Deviations

Class IIModerate

FDAJul 10, 2025Nationwide• A.P. Deauville, LLC

Semaglutide Injection 4mL (Boothwyn Pharmacy) – Subpotent Drug (2025)

Subpotent Drug

Class IIModerate

FDAJul 9, 2025Nationwide• Boothwyn Pharmacy LLC

Semaglutide Injection (Boothwyn Pharmacy) – Subpotent Drug (2025)

Subpotent Drug

Class IIModerate

FDAJul 9, 2025Nationwide• Boothwyn Pharmacy LLC

1...3 456 7...28

Page 5 of 28Next